OptimizeRx Statistics Share Statistics OptimizeRx has 18.5M
shares outstanding. The number of shares has increased by 0.95%
in one year.
Shares Outstanding 18.5M Shares Change (YoY) 0.95% Shares Change (QoQ) 0.03% Owned by Institutions (%) 63.53% Shares Floating 16.75M Failed to Deliver (FTD) Shares 1,068 FTD / Avg. Volume 0.32%
Short Selling Information The latest short interest is 1.15M, so 6.2% of the outstanding
shares have been sold short.
Short Interest 1.15M Short % of Shares Out 6.2% Short % of Float 6.57% Short Ratio (days to cover) 7.2
Valuation Ratios The PE ratio is -4.42 and the forward
PE ratio is 26.29.
OptimizeRx's PEG ratio is
-0.65.
PE Ratio -4.42 Forward PE 26.29 PS Ratio 0.97 Forward PS 2.6 PB Ratio 0.76 P/FCF Ratio 18.61 PEG Ratio -0.65
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for OptimizeRx.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.89,
with a Debt / Equity ratio of 0.28.
Current Ratio 2.89 Quick Ratio 2.89 Debt / Equity 0.28 Debt / EBITDA -3.73 Debt / FCF 6.95 Interest Coverage -2.23
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $719.74K Profits Per Employee $-157.11K Employee Count 128 Asset Turnover 0.54 Inventory Turnover n/a
Taxes Income Tax 725K Effective Tax Rate -3.74%
Stock Price Statistics The stock price has increased by 94.36% in the
last 52 weeks. The beta is 1.33, so OptimizeRx's
price volatility has been higher than the market average.
Beta 1.33 52-Week Price Change 94.36% 50-Day Moving Average 13.46 200-Day Moving Average 8.4 Relative Strength Index (RSI) 73.31 Average Volume (20 Days) 332,690
Income Statement In the last 12 months, OptimizeRx had revenue of 92.13M
and earned -20.11M
in profits. Earnings per share was -1.1.
Revenue 92.13M Gross Profit 59.38M Operating Income -13.71M Net Income -20.11M EBITDA -8.9M EBIT -13.22M Earnings Per Share (EPS) -1.1
Full Income Statement Balance Sheet The company has 13.38M in cash and 33.19M in
debt, giving a net cash position of -19.81M.
Cash & Cash Equivalents 13.38M Total Debt 33.19M Net Cash -19.81M Retained Earnings -84.37M Total Assets 167.77M Working Capital 33.36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 4.89M
and capital expenditures -112K, giving a free cash flow of 4.78M.
Operating Cash Flow 4.89M Capital Expenditures -112K Free Cash Flow 4.78M FCF Per Share 0.26
Full Cash Flow Statement Margins Gross margin is 64.45%, with operating and profit margins of -14.88% and -21.83%.
Gross Margin 64.45% Operating Margin -14.88% Pretax Margin -21.04% Profit Margin -21.83% EBITDA Margin -9.66% EBIT Margin -14.88% FCF Margin 5.19%
Dividends & Yields OPRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for OPRX is $12,
which is -26% lower than the current price. The consensus rating is "Buy".
Price Target $12 Price Target Difference -26% Analyst Consensus Buy Analyst Count 8
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 14, 2018. It was a
backward
split with a ratio of 1:3.
Last Split Date May 14, 2018 Split Type backward Split Ratio 1:3
Scores Altman Z-Score 3.6 Piotroski F-Score 4
